Large-scale in vitro bovine embryo production systems commonly use genital tracts obtained from an abattoir as a source of both cumulus\p=n-\oocytecomplexes and co-culture feeder cells. Tissues derived from this source may be contaminated with non-cytopathogenic bovine viral diarrhoea virus (BVDV) since, in several countries surveyed, approximately 1% of animals tested are persistently infected with this pathogen. Therefore, the use of such material in in vitro fertilization systems presents a potential risk for the transmission of BVDV to bovine embryos and via embryo transfer. This potential was investigated by obtaining oviduct epithelial cells and granulosa cells, which are commonly used as feeder cells, from cattle persistently infected with BVDV and examining them for the presence of BVD viral antigen (p80 non-structural protein and gp53 envelope glycoprotein) by indirect immunofluorescent histochemistry, and also viral RNA (encoding the p80 region) by in situ hybridization. In addition, titres of virus present in oviduct, ovary and blood were assayed by immunodetection on calf testis cell cultures. Luminal epithelial cells from the oviduct and primary cultures of granulosa cells and oviduct epithelial cells from such cattle were shown to contain both viral antigen and RNA. The susceptibility of both cell types to BVDV infection was further established by inoculating primary cell cultures of cells derived from cattle not infected with BVDV with a cloned isolate of non-cytopathogenic BVDV (Pe515). RNA encoding BVDV and the antigen were detected 12 h after inoculation. Viral titres present in oviduct, ovary and blood were between \m=ge\102.2 and 107; \m=ge\102.2 and 106.75; and 103.5 and 104.25 tissue culture infective doses, (TCID)50 g \ m=-\ 1, respectively. Control tissues from cattle not infected with BVDV, tested in each of the preceding techniques, were negative. These data establish that ovary and oviduct of persistently infected animals harbour non-cytopathogenic BVDV and that granulosa cells and oviduct epithelial cells, which are used as co-culture cells during bovine embryonic development in vitro and which, in the case of granulosa cells, constitute the cumulus investment surrounding the oocyte, are a vehicle for the potential transmission of BVDV to developing embryos.
Introduction
Recommendations have been published by the Office International Des Epizooties (Singh, 1985) and the International Embryo Transfer Society (IETS, 1990) detailing sanitary proce¬ dures required for bovine embryo transfer to prevent trans¬ mission of infectious agents. These measures include health certification of donor cattle, implementation of recommended washing procedures, removal of adherent debris and rejection of embryos with damaged zonae pellucidae. In addition, the microbial status of embryo flush and transfer fluids has also received attention, particularly bovine serum, which is routinely incorporated into these solutions and cell culture media. Such sera, and indeed bovine tissues, may be infected with bovine viral diarrhoea virus (BVDV), which has been recognized as a potential contaminant of cell cultures (Nuttal et al, 1977; Rossi et al, 1980) . Less attention has been paid to the use of oviduct epithelial cells (OECs) and granulosa cells (GCs) as co-culture cells during production in vitro of bovine embryos, which generate a supplementary potential source of infection, particularly as these cells are commonly derived from abattoirs and are of unknown health status.
The literature suggests that, provided sanitary guidelines are implemented, the risk of transmission of bovine viruses by embryo transfer is extremely small. However, not all infectious bovine viral agents have been studied with respect to germline transmission, or the research has been limited or inconclusive (IETS, 1990 (IETS, , 1992 , and there is still speculation concerning the potential transmission of BVDV by embryo transfer.
The BVD virus exists as two biotypes of different cytopathogenicity, distinguished by their effect in cell culture (Brownlie, 1985) . Preliminary studies indicated that the cytopathogenic variant cannot infect embryos in vitro (although a potential contradiction to these data was presented by Archbald et al, 1979) , and cannot be transmitted by embryo transfer (Singh et al, 1982; Potter et al, 1984; Bielanski and Hare, 1988 ). Furthermore, this biotype cannot establish a persistent infection in the early fetus (Brownlie et al, 1989) . In contrast, inoculation in utero of the noncytopathogenic variant may precipitate an immunotolerant persistent condition (McClurkin et al, 1984) , thus demonstrating a clear difference in fetal pathogenicity between the two biotypes. The noncytopathogenic virus is evidently capable of vertical trans¬ mission (Straver et al, 1983; Radostits and Littlejohns, 1988) , but the earliest stage of development in vivo at which viral infection of the oocyte or embryo can occur has not been described. Brock and Stringfellow (1993) reported that viral antigen can be expressed in blastocysts as early as day 14 after hatching after infection in vitro. In the absence of evidence to suggest that the zona pellucida is a barrier to the noncytopathogenic biotype, concern that prehatched transferable embryos are susceptible to viral infection is justified. Two reports (Bak et al, 1992; Wentink et al, 1991 ) that three non-viraemic calves were born after embryo transfer from donors that are persistently infected with BVDV are insufficient evidence to conclude that the risk of transmission is negligible. Until prehatched bovine embryos are shown to be resistant to the non-cytopathogenic virus, procedures to eliminate BVDV contamination during IVF and embryo transfer protocols should be implemented.
The intention of this study was to investigate whether granulosa and oviduct epithelial cells used as co-culture cells in IVF protocols and embryo transfer procedures are susceptible to infection by non-cytopathogenic BVDV, and therefore act as vehicles for the potential transmission of this agent to bovine embryos.
Materials and Methods
Animals, tissue preparation and cell culture Six persistently infected animals were acquired from the Institute for Animal Health (Compton) and the University of Liverpool, namely, 1280 (7 weeks old, Friesian), NF5349 (18 months old, Aberdeen Angus), S2HS (23 months old, Friesian heifer), LL (16 months old, Aberdeen Angus), LS (11 months old, Aberdeen Angus) and DP197 (19 months old, Friesian heifer, 120 days pregnant). Control animals, which were free from BVD virus (as determined by virus isolation techniques on whole blood samples) were also acquired.
Ovaries, oviducts and EDTA-treated blood samples were collected after death. Tissues that were used immediately from the laboratory abattoir were stored in 0.01 mol PBS 1~ (pH 7.2) while those transported ( < 4 h) were collected in medium E199 (plus Earle's salts and bicarbonate; Sigma, St Louis, MO) containing 50 iu penicillin GmP1 (Sigma) and 0.05 mg streptomycin ml~' (Sigma) and stored between 20 and 37°C Cryoblocks of oviduct were prepared in OCT embedding medium (Miles Inc., Elkhart). Oviduct segments destined for in situ hybridization were fixed in neutral buffered formalin and embedded in paraffin wax, as described by Desport el al (1992) . Further sections of oviduct were frozen at -70°C for virus titration. Ovarian follicles were aspirated by syringe to recover follicular fluid containing granulosa cells.
Follicular fluid was centrifuged (175 g, 5 min) and the cell pellet was washed twice in 5 ml tissue culture medium (TCM; medium E199 plus Earle's salts and bicarbonate containing 50 iu penicillin G ml~, 0.05 mg streptomycin ml~, 4 mmol glutamine 1~\ 0.2 mmol pyruvate 1~, 20.9 mmol lactate 1' (Sigma)) and 10% (v/v) oestrous cow serum (Institute for Animal Health farm). The serum was negative for both BVD virus and antibody. Cells were finally resuspended in TCM and seeded into culture flasks (Becton Dickinson, Bedford, MA) or six-well plates (Nunc, Roskilde) containing glass coverslips and incubated at 37°C in 5% C02 in air.
OECs were recovered from the remaining sections of oviduct by the method of Eyestone and First (1989) with minor modifications. Briefly, mesenteric tissue was dissected from the oviduct and washed in 70% (v/v) ethanol and blotted dry. Epithelial cells were extruded by squeezing along the length of each oviduct with forceps. Cells were disaggregated by repeti¬ tive aspiration with a pipette and then washed and seeded into culture vessels as detailed for granulosa cells.
Calf testis cell (CTe) fibroblasts were derived from < 5-dayold animals and prepared according to a standard primary culture technique (Freshney, 1987) .
The susceptibility of OECs, GCs and CTe cells to infection with BVDV in vitro was also investigated. Confluent primary cell cultures derived from animals not infected with BVDV were inoculated with a non-cytopathogenic strain of BVDV (Pe515; 1 104 tissue culture infective dose (TCID)50 ml" x) at a multiplicity of infection of approximately one. Initially, the inoculum was added for 2 h in a limited volume to facilitate viral adsorption. The cultures were terminated at 3, 6, 9, 12, 24 h and 3 days after infection.
Coverslip cultures of GCs and OECs for immunofluorescent staining were fixed in acetone. GCs and OECs cultured in flasks and destined for staining by in situ hybridization were cytospun (400 g, 7 min) onto slides coated with aminopropyltriethoxysilane and fixed in acetone. Before cytospinning, GCs were resuspended in TCM by a standard trypsinization method (Freshney, 1987) , whereas OECs were resuspended using a cell scraper.
Virus isolation and enzyme-linked immunosorbent assay
Tissue samples (0.1-0.2 g) destined for viral titration were ground to a paste in a mortar and pestle using sterile sand. CTe medium was added to achieve a 10% (w/v) suspension, which was centrifuged (700 g-, 5 min) to provide a supernatant fluid suitable for inoculation.
CTe cultures of passage 3-8 were grown on coverslips in six-well plates or test tubes in CTe Medium. The latter comprised Eagle's basal medium (Modified; ICN Flow Biomedicals, Thame) containing 8.2% (v/v) fetal calf serum (Gibco, Paisley), 2.34 mg lactalbumin ml , 2 mmol L-glutamine 1~' , 1.05 mg sodium bicarbonate ml-, 100 U penicillin ml-1, 100 µg streptomycin ml~' and 25 U mycostatin ml~' (Sigma). Viral adsorption was permitted by adding inocula to wells or test tubes containing a reduced volume of medium, to maxi¬ mize viral adherence to CTe monolayers. After incubating for 1.5-2.0 h, inocula that were potentially toxic were decanted and the volumes of the vessels were readjusted with CTe medium. The cells were incubated at 38.5°C in 5% C02 in air for 7 days and BVDV was detected by immunofluorescent staining. This technique was used to determine viral titres in oviduct, ovary and blood.
The ELISA was based on a method developed by Voller and Bidwell (1976) and adapted by Howard et al (1985) with minor modifications.
Immunofluorescent staining
Cryosections (8-10 µ thick) were cut onto slides coated with 3-aminopropyItriethoxysilane (Sigma) and fixed in acetone. Sections were stained by an indirect immunofluores¬ cent technique. Briefly, preparations were incubated with 1:20 normal swine serum (Gibco), and then the monoclonal anti¬ body, and subsequently goat anti-mouse immunoglobulin conjugated to fluorescein isothiocyanate (FITC; Southern Bio¬ technology Associates Inc., Birmingham, AL). Preparations were mounted in 80% (v/v) glycerol containing 2.5% (w/v) l,4-diazabicyclo-[2.2.2]octane (DABCO; Sigma). Reagents for an alternative staining protocol were sheep anti-mouse IgG conjugated to biotin (Serotec, Slough), and then streptavidin-FITC conjugate (Amersham International, Amersham). All re¬ agents were diluted in 1:20 normal swine serum to reduce nonspecific binding. The immunofluorescent staining technique was performed on cryosections of oviduct and coverslip cultures of GCs, OECs and CTe cells.
Anti-BVDV monoclonal antibodies were specific to the nonstructural p80 protein of BVDV (antibodies: WB112, WB103) and to the viral envelope glycoprotein gp53 (antibody WB162). The immunoglobulin isotypes of the antibodies were: WB103, WB162; IgGl: WB112; IgG2a. The specificity of immunofluorescent staining was established using monoclonal antibodies to respiratory syncytial virus (RSV) of identical isotype (RSV22, IgG2a: RSV32, IgGl) to that of the BVDV antibodies. Nonspecific staining reactions were also detected by including a mouse anti-chicken monoclonal antibody (AVII; specific to a surface marker of mature chicken white blood cells) with every test. Specific binding of the conjugates was tested by substitution of the BVDV antibodies or sheep anti-mouse biotin reagent with normal swine serum. Each of the above tests for specificity was performed on potentially infected and noninfected control tissue.
In situ hybridization
The detection of RNA encoding BVDV in cytospun cell preparations and on oviduct formalin-fixed, paraffin-wax embedded histosections by in situ hybridization was performed using a digoxigenin-labelled riboprobe as described by Desport et al. (1992) . Briefly, the 758 base riboprobe was derived from a highly conserved region of the BVDV genome encoding a portion of p80 (Collett et al, 1989) . After hybridization, the bound probe was detected by incubating with sheep antidigoxigenin Fab fragments conjugated to alkaline phos¬ phatase (Boehringer Mannheim, Mannheim). This preceded a colour reaction involving substrate NBT/BCIP (Promega, Southampton). The specificity of hybridization was investi- 
Results
Isolation of BVDV and antigen detection Conventional virus isolation techniques established the presence of BVDV in every blood sample and ovarian and oviductal tissue sample obtained from persistently infected animals (Table 1 ). Among animals, titres of virus measured in ovary and oviduct varied 100-fold. Within animals, the viral titres recorded in these same tissues were, in samples that had been completely titrated, in excess of those observed in corresponding blood samples. BVDV antigen, detected by immunofluorescent staining, was present in epithelial cells of oviduct cryosections of all the persistently infected animals investigated. The magnitude of the fluorescent staining in the cells of the epithelia ranged from very intense to an absence of labelling. Staining was also evident in the lamina propria (Fig. la) , the inner and outer muscularis, the tunica media of blood vessels and the serosa.
The serosa and lamina propria generally produced weaker staining than did other areas and were occasionally negative.
Similarly, coverslip primary cultures of GCs (Fig. le) and OECs (Fig. 1c ) derived from five persistently infected cattle and stained by immunocytochemistry exhibited fluorescence rang¬ ing among animals from intense to weak (Table 2) . Immuno¬ fluorescence was also observed in primary cell cultures of GCs (Fig. If) and OECs (Fig. id) (Table 2) . Variations in the immunoreactivities of the panel of BVDV monoclonal antibodies used, in relation to the field strain of BVDV present, were evident by the absence of labelling in all tissues tested from animal DP197 after immuno¬ histochemistry using antibody WB162. The remaining anti¬ bodies all produced immunofluorescent signals in tissues of this animal, and all three BVDV antibodies tested produced immunostaining in tissues of all other BVDV-infected animals investigated.
Immunofluorescence was not observed in every cell of either cryosections or coverslip cultures. When present, stain¬ ing was cytoplasmic and not in the nucleus, a cellular distribution characteristic of this RNA virus. The specificity of the immunocytological staining was investigated by stan¬ dard techniques. Immunofluorescence greater than nonspecific background intensity was absent when coverslip primary cell cultures and tissue sections derived from BVD virus-free animals were incubated with the BVDV-specific monoclonal antibodies (Fig. lb) . Substitution of BVDV-specific antibodies with control antibodies specific to bovine respiratory syncytial virus antigens (RSV22, RSV32) and to a chicken lymphocyte surface marker (AVll), which were of identical immunoglobulin isotypes to the BVDV monoclonals, all produced no visible immunoreactivity greater than the nor¬ mal faint background intensity in tissues derived from BVDV-infected animals. The specificity of the fluorescein isothiocyanate-labelled secondary antibody was shown by the absence of immunofluorescence in BVDV-infected tissues incubated with the conjugate alone.
Detection of mRNA encoding BVDV
An intense positive hybridization signal for RNA encoding BVDV was observed in the epithelial cells of oviduct cryo¬ sections prepared from BVDV-infected cattle (Fig. 2a ). Within this tissue, staining was also detected in cells of the lamina propria. Primary cultures of OECs (Fig. 2c,d) and GCs (Fig.   2f ,g) acquired from BVDV-infected animal LS and subjected to cytocentrifugation preceding the in situ hybridization protocol also revealed the presence of mRNA encoding BVDV, which is characterized by blue staining in isolated cells and groups of cells. Oviduct epithelial cells ( Fig. 2e ) and granulosa cells cultured from control animals not infected with BVDV and inoculated in vitro with BVDV strain Pe515 presented a strong signal to in situ hybridization. A characteristic cytoplasmic pattern of staining was recorded, supporting the results of the immunofluorescence staining. In some cells, the differential staining pattern was obscured by intense cytoplasmic labelling ( Fig. 2c ,e,f). Again, only a proportion of the cells on each slide showed positive staining for viral RNA, indicating that not all of the cells in the source material, or after infection in vitro, harboured BVDV. Furthermore, the intensity of the (a) Oviduct cryosection from a BVDV-infected animal (LL) immunostained with monoclonal antibody WB112 (specific to BVDV nonstructural protein p80). Cells of the epithelial layer (E) exhibited immunofluorescence ranging from very intense to an absence of signal (indicated by arrows). Within BVDV-immunoreactive epithelial cells, nonstaining basally located nuclei can be observed. BVDV antigen was not detected within the oviductal lumen (L). Cells within the lamina propria (LP) exhibited immunoreactivity, which in the lower mucosal fold is quite intense, (b) The tip of one mucosal fold of an oviductal cryosection from a control animal that was not infected with BVDV (H232) immunostained with the same monoclonal antibody as in (a). This print has been overexposed deliberately to increase the limited histological detail present. No BVDV-specific immunoreactivity is evident, (c) Primary culture of oviduct epithelial cells derived from a BVDV-infected animal (S2HS) and incubated with monoclonal antibody WB112. Variation in the intensity of cytoplasmic staining is observed between cells. Staining, when present, is strictly cytoplasmic and non-nuclear, (d) Primary culture of oviduct epithelial cells derived from a control animal that was not infected with BVDV (HD393) 96 h after inoculation in vitro with non-cytopathogenic BVDV (Pe515), stained with monoclonal antibody WB162 (specific to the BVDV envelope glycoprotein gp53). (e) Primary culture of granulosa cells from a BVDV-infected animal (NF5349) stained with antibody WB162. (f) Primary culture of granulosa cells derived from an animal that was not infected with BVDV (H8296), which had been inoculated in vitro with BVDV. The culture was terminated 48 h after inoculation and stained with antibody WB103 (specific to the BVDV p80 nonstructural protein). ). (a) In situ hybridization, using the BVDV riboprobe, on a histological section of an oviduct taken from a BVDV-infected animal. Intense staining is present within the epithelial layer (E) and also within isolated cells of the lamina propria (LP) . Staining that is apparently present within the oviduct lumen (L) is that on epithelial cells of neighbouring mucosal tissue, (b) Adjacent serial section to that shown in panel (a), demonstrating the nonspecific background hybridization signal when using the control neomycin resistance probe at an equal concentration to that of the BVDV riboprobe. (c) Cytocentrifuged cell preparation of a primary culture of OECs from a persistently BVDV-infected animal (LS) hybridized with the BVDV specific riboprobe. (d) A similarly cytospun OEC preparation to that shown in (c), demonstrating nonspecific background staining using the neomycin resistance probe, (e) Hybridization of the BVDV riboprobe to cytocentrifuged samples of OECs derived from a BVDV-free animal and infected in vitro with strain Pe515. (f) A cytospun sample from a primary culture of GCs derived from a BVDV-infected animal, demonstrating the presence of viral RNA using the BVDV-specific riboprobe. (g) Nonspecific hybridization signal generated using the neomycin resistance probe on a similar cell preparation to that detailed in panel (f) . hybridization signal varied between cells and ranged from weak to very prominent staining (Fig. 2c,e,f) .
The conditions used for the in situ hybridization were physically harsh and in many cases a high degree of cell loss was observed from cytospun preparations. The use of slides coated with 3-aminopropyltriethoxysilane remedied this to some degree, but care had to be exercised at all stages of the hybridization and detection procedures. It was important to control for nonspecific staining of cells, as the reporter enzyme, alkaline phosphatase, is widely distributed in biological material and is physically robust. This was achieved in several ways, but initially by the addition of enzyme substrate solution to cells that had been subjected to identical reaction conditions but to which no riboprobe had been hybridized. These control results were negative under the conditions used. This finding is important, as alterations in the fixation or hybridization condi¬ tions could lead to a failure to quench endogenous alkaline phosphatase enzymes, resulting in false positive reactions. Staining was not generated using the neomycin resistance probe on BVDV-infected cell samples (Fig. 2b,d ,g) nor observed in samples derived from animals that were not infected with BVDV hybridized with either riboprobe.
Discussion
The diagnostic techniques applied in this investigation have established that GCs and OECs are susceptible to infection by the non-cytopathogenic biotype of BVDV. These data add to information concerning the pathogenesis of this virus in the reproductive tract of cows and have important implications for IVF and embryo transfer programmes in terms of the potential transmission of this pathogen. The detection of noncytopathogenic BVDV in the epithelial tissues of the oviduct and ovary supplements the evidence that epithelial cells in general, together with the central nervous system and lymphoid tissues, are predeliction sites for this virus (Ohmann et al, 1981; Ohmann, 1983; Allan et al, 1989; Desport et al, 1992) . Tissues underlying epithelial layers may also be infected in gastrointestinal and reproductive tissues (Ohmann, 1983; Kirkland et al, 1991) (1980) reported that 63% (13 of 21) of commercial nonirradiated sera were BVDV-positive. As cell lines derived from persistently infected animals are likely to be similarly contaminated (Nuttal et al, 1977; Rossi et al, 1980) , the use of co-culture cells obtained from ovaries from cows of unknown health status from abattoirs is a cause for concern. The virus has been isolated from degenerate ova that had been fertilized and co-cultured in the presence of oviduct cells previously infected with BVDV (Zurovac et al, 1994) . At an earlier stage of development in vitro, whole batches of cumulus-oocyte com¬ plexes may be infected if tissues from persistently infected animals are used. Considering the large number of ovaries acquired from abattoirs by commercial companies engaged in embryo generation, and the evidence that approximately 1% of animals in an abattoir may be infected (Howard et al, 1986 , and references therein), contamination of culture systems by BVDV is not an unlikely event. Avery el al (1993) reported that 12% of their in vitro embryo production system experiments were contaminated with BVDV, and BVD virus was isolated from 1.2% of oviduct cell samples tested and destined for use during culture in vitro (Bielanski et al, 1993) .
The capacity of non-cytopathogenic BVDV to infect the cells of the prehatched embryo or to adhere to the zona pellucida still remains unresolved. Certainly after hatching, viral antigen can be expressed in embryos at day 14 after exposure to the non-cytopathogenic biotype in vitro (Brock and Stringfellow, 1993) . If BVDV infection is permissible in trophectoderm or inner cell mass cells after hatching, such cells may even be susceptible in blastocysts during prehatching development (the time at which embryos are transferred to recipients) if the virus can penetrate the zona pellucida. An undamaged zona pellucida may present a barrier to viral penetration of the oocyte or embryo, but may be liable to being breached at specific stages of development or under certain conditions. This could occur during or after fertilization, perhaps facilitated by the penetration tract of the spermato¬ zoon through the zona (Guerin et al, 1992) or subsequent to damage and cracking of the zona during cryopreservation (Rail and Meyer, 1989) or as a consequence of micromanipulation procedures.
Until it has been proved unequivocally that the bovine embryo is not susceptible to infection by non-cytopathogenic BVDV or it has been shown that adherent virus can be removed by washing techniques, commercial companies pro¬ ducing embryos generated in vitro, and those engaged in embryo transfer, are recommended to screen for the presence of this virus.
